ALGS vs REGN: Which Stock is Better?

Side-by-side comparison of Aligos Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ALGS

Aligos Therapeutics Inc

$6.00

REGN

Regeneron Pharmaceuticals Inc

$707.06

Key Metrics Comparison

MetricALGSREGNWinner
Market Cap$36.94M$71.96BREGN
P/E RatioN/A16.54REGN
EPS (TTM)$N/A$41.49REGN
Revenue Growth-0.7%0.0%REGN
Gross Margin-3077.2%44.6%REGN

Analyze ALGS

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ALGS or REGN a better investment?

Comparing ALGS and REGN: Aligos Therapeutics Inc has a market cap of $36.94M while Regeneron Pharmaceuticals Inc has $71.96B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ALGS and REGN?

ALGS (Aligos Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ALGS or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ALGS or REGN?

REGN has higher revenue growth at 0.0% vs -0.7% for ALGS.

Which company is more profitable: ALGS or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -3077.2% for ALGS.

Which is the larger company: ALGS or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $71.96B compared to $36.94M for ALGS.

Should I buy ALGS or REGN in 2026?

Both ALGS and REGN have investment merit. ALGS trades at $6.00 while REGN trades at $707.06. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ALGS and REGN stock?

Key differences: Market Cap ($36.94M vs $71.96B), P/E Ratio (N/A vs 16.5x), Revenue Growth (-0.7% vs 0.0%), Gross Margin (-3077.2% vs 44.6%).

Popular Stock Comparisons